99009599
Jan 17, 2025
Active pharmaceutical ingredients, namely lutetium-177, for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely non-carrier added lutetium-177; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; active pharmaceutical ingredients, namely terbium-149, terbium-152, terbium-155, or terbium-161; active pharmaceutical ingredients, namely actinium-225; parent radioisotopes for the preparation of active pharmaceutical ingredients, namely molybdenum-99
Pharmaceuticals